[1] 柏玉娣,施茂林,李思琪,等. 程序性死亡蛋白配体1在CD133+人肝癌干样细胞中的表达及功能研究. 中华肿瘤杂志,2023,45(2):117-128. [2] 刘瑜,杨文静,郭玮. 肝细胞肝癌患者根治性切除术后复发相关血清标志物的研究进展. 中华检验医学杂志,2023,46(1):93-97. [3] 彭雨,李海涛,杨文丽,等. PD-1抑制剂联合仑伐替尼治疗老年中晚期原发性肝癌患者临床疗效研究. 实用肝脏病杂志,2023,26(1):112-115. [4] Komoll RM, Hu Q, Olarewaju O, et al. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma. J Hepatol, 2021,74(1):122-134. [5] Liu Y, Lu LL, Wen D, et al. MiR-612 regulates invadopodia of hepatocellular carcinoma by hadha-mediated lipid reprogramming. J Hematol Oncol, 2020,13(1):12-23. [6] Liu N, Wang X, Steer CJ, et al. MicroRNA-206 promotes the recruitment of CD8+ T cells by driving m1 polarisation of Kupffer cells. Gut, 2022,71(8):1642-1655. [7] Xu WP, Liu JP, Feng JF, et al. MiR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy. Gut, 2020,69(7):1309-1321. [8] Liu D, Kang H, Gao M, et al. Exosome-transmitted circ_mmp2 promotes hepatocellular carcinoma metastasis by upregulating MMP2. Mol Oncol, 2020,14(6):1365-1380. [9] Li J, Hu ZQ, Yu SY, et al. Circrpn2 inhibits aerobic glycolysis and metastasis in hepatocellular carcinoma. Cancer Res, 2022,82(6):1055-1069. [10] Yin S, Jin W, Qiu Y, et al. Solamargine induces hepatocellular carcinoma cell apoptosis and autophagy via inhibiting lif/mir-192-5p/cyr61/akt signaling pathways and eliciting immunostimulatory tumor microenvironment. J Hematol Oncol, 2022,15(1):32-39. [11] Wei X, Zhao L, Ren R, et al. MiR-125b loss activated hif1-α/p-akt loop, leading to transarterial chemoembolization resistance in hepatocellular carcinoma. Hepatology, 2021,73(4):1381-1398. [12] Shi T, Morishita A, Kobara H, et al. The role of long non-coding RNA and microRNA networks in hepatocellular carcinoma and its tumor microenvironment. Int J Mol Sci, 2021,22(19):10630-10639. [13] Kim GW, Imam H, Khan M, et al. HBV-induced increased n6 methyladenosine modification of pten rna affects innate immunity and contributes to hcc. Hepatology, 2021,73(2):533-547. [14] Zhou H, Du Y, Wei X, et al. DDX56 transcriptionally activates mist1 to facilitate tumorigenesis of hcc through pten-akt signaling. Theranostics, 2022,12(14):6069-6087. [15] Gui L, Zhang S, Xu Y, et al. Ube2s promotes cell chemoresistance through pten-akt signaling in hepatocellular carcinoma. Cell Death Discov, 2021,7(1):357. [16] Luo YD, Fang L, Yu HQ, et al. P53 haploinsufficiency and increased mtor signalling define a subset of aggressive hepatocellular carcinoma. J Hepatol, 2021,74(1):96-108. [17] Xu G, Bu S, Wang X, et al. MiR-122 radiosensitize hepatocellular carcinoma cells by suppressing cyclin g1. Int J Radiat Biol, 2022,98(1):11-17. [18] Xu D, Wang Y, Wu J, et al. Ect2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ect2/plk1/pten pathway. Cell Death Dis, 2021,12(2):162-172. |